Identification of retroviral DNA sequences in serum of cutaneous forms of lupus erythematosus patients

European Journal of Dermatology

Volumn 13, Issue 4, 2003, Pages 354-358

  Prokop, Janusz ^a   Jagodzinski, Pawel P ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Anti nuclear antibodies; Endogenous retroviruses; Lupus erythematosus

Indexed keywords

DNA ANTIBODY; DOUBLE STRANDED DNA; POL PROTEIN; VIRUS DNA;

ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISCOID LUPUS ERYTHEMATOSUS; DNA SEQUENCE; DOT HYBRIDIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; RETROVIRUS; SEQUENCE HOMOLOGY; STRUCTURAL GENE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODIES, ANTINUCLEAR; CASE-CONTROL STUDIES; DNA; DNA PRIMERS; DNA, SINGLE-STRANDED; DNA, VIRAL; HIV-1; HUMANS; IMMUNOBLOTTING; LUPUS ERYTHEMATOSUS, CUTANEOUS; LUPUS ERYTHEMATOSUS, DISCOID;

EID: 0042661155     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Wolska H, Blaszczyk M, Jablonska S. Phototests in patients with various forms of lupus erythematosus. Int J Dermatol 1989; 28: 98-103.
2. Beutner EH, Blaszczyk M, Jablonska S, Chorzelski TP, Kumar V, Wolska H. Studies on criteria of the European Academy of Dermatology and Venerology for the classification of cutaneous lupus erythematosus. I. Selection of clinical groups and study factors. Int J Dermatol 1991; 130: 411-27.
3. Love LA. New environmental agents associated with lupus-like disorders. Lupus 1994; 3: 467-71.
4. Norris DA. Pathomechanisms of photosensitive lupus erythematosus. J Invest Dermatol 1993; 100: 58-68.
5. Kalden JR. Defective phagocytosis of apoptotic cells: possible explanation for the induction of autoantibodies in SLE. Lupus 1997; 6: 326-7.
6. Casciola-Rosen L, Rosen A. Ultraviolet light-induced keratinocyte apoptosis: a potential mechanism for the induction of skin lesions and autoantibody production in LE. Lupus 1997; 6: 175-80.
7. Kalden JR, Winkler TH, Herrmann M, Krapf F. Pathogenesis of SLE: immunopathology in man. Rheumatol Int 1991; 11: 95-100.
8. Nakajima M, Nakajima A, Kayagaki N, Honda M, Yagita H, Okumura K. Expression of Fas ligand and its receptor in cutaneous lupus: implication in tissue injury. Clin Immunol Immunopathol. 1997; 83: 223-9.
9. Rosen A, Casciola-Rosen L, Ahearn J. Novel packages of viral and self-antigens are generated during apoptosis. J Exp Med 1995; 181: 1557-61.
10. Pravost TT, Watson R. Anti-Ro (SS-A) HLA-DR3-positive women: the interrelationship between some ANA negative, SS, SCLE, and NLE mothers and SS/LE overlap female patients. J Invest Dermatol 1993; 100: 14-20.
11. Datta SK, Patel H, Berry D. Induction of a cationic shift in IgG anti-DNA autoantibodies. Role of T helper cells with classical and novel phenotypes in three murine models of lupus nephritis. J Exp Med 1987; 165: 1252-68.
12. Pirner K, Rascu A, Nurnberg W, Rubbert A, Kalden JR, Manger B. Evidence for direct anti-heparin-sulphate reactivity in sera of SLE patients. Rheumatol Int 1994; 14: 169-74.
13. Fillit H, Shibata S, Sasaki T, Spiera H, Kerr LD, Blake M. Autoantibodies to the protein core of vascular basement membrane heparan sulfate proteoglycan in systemic lupus erythematosus. Autoimmunity 1993; 14: 243-9.
14. Hishikawa T, Ogasawara H, Kaneko H, Shirasawa T, Matsuura Y, Sekigawa I, Takasaki Y, Hashimoto H, Hirose S, Handa S, Nagasawa R, Maruyama N. Detection of antibodies to a recombinant gag protein derived from human endogenous retrovirus clone 4-1 in autoimmune diseases. Viral Immunol 1997; 10: 137-47.
15. Leib-Mosch C, Brack-Werner R, Werner T, Bachmann M, Faff O, Erfle V, Hehlmann R. Endogenous retroviral elements in human DNA. Cancer Res 1990; 50: 5636-42.
16. Talal N, Garry RF, Schur PH, Alexander S, Dauphinee MJ, Livas IH, Ballester A, Takei M, Dang H. A conserved idiotype and antibodies to retroviral proteins in systemic lupus erythematosus. J Clin Invest. 1990; 85: 1866-71.
17. Ogasawara H, Naito T, Kaneko H, Hishikawa T, Sekigawa I, Hashimoto H, Kaneko Y, Yamamoto N, Maruyama N, Yamamoto N. Quantitative analyses of messenger RNA of human endogenous retrovirus in patients with systemic lupus erythematosus. J Rheumatol 2001; 28: 533-8.
18. Urnovitz HB, Murphy WH. Human endogenous retroviruses: nature, occurrence, and clinical implications in human disease. Clin Microbiol Rev 1996; 9: 72-99.
19. Weller TH, Caans AH. Fluorescent antibody studies with agents of varicella and herpes zoster propagated in vitro. Proc So Exp Biol Med 1954; 86: 789-94.
20. Simpson L. Behavior of the kinetoplast of Leishmania tarentolae upon cell rupture. J Protozool 1968; 15: 132-6.
21. Herrmann M, Kalden JR. PCR and reverse dot hybridization for the detection of endogenous retroviral transcripts. J Virol Methods 1994; 46: 333-48.
22. Armitage P. Statistical methods in medical research 3rd ed. Oxford: Blackwell Scientific Publications 1971.
23. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, Chen IS. HIV-1 entry inta quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 1990; 20: 213-22.
24. Haraguchi S, Good RA, Cianciolo GJ, Engelman RW, Day NK. Immunosuppressive retroviral peptides: immunopathological implications for immunosuppressive influences of retroviral infections. J Leukac Biol 1997; 6: 654-66.
25. Koshino K, Tokano Y, Hishikawa T, Sekigawa I, Hashimoto TY. Detection of antibodies to HIV-1 gp41- and HLA class II antigen-derived peptides in SLE patients. Scand J Rheumatol 1995; 24: 288-92.
26. Perl A. Endogenous retroviruses in pathogenesis of autoimmunity. J Rheumatol 2001; 28: 461-64.